Sanofi (ADR) (SNY)
Develops immunology-focused medicines and vaccines across a broad international footprint.
$42.25
vs last close−0.25 (−0.59%)
Something off on this page? Send us feedback.
Next report
Oct 30, 26
estimated · in 38 days
EPS estimate
$1.72
Revenue estimate
$15.20B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$0.70$0.94$0.90$1.70$0.89$1.10$1.21Pending
Estimate$0.71$0.90$0.96$1.60$0.84$1.06$1.10$1.72
Surprise−1.4%+4.4%−6.2%+6.2%+6.0%+3.8%+10.0%—
RevenueReportedEstimate
Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$7.90B$11.63B$12.64B$15.43B$14.34B$12.94B$14.06BPending
Estimate$9.51B$10.00B$12.36B$11.11B$11.71B$12.68B$15.34B$15.20B
Surprise−16.9%+16.3%+2.3%+38.9%+22.4%+2.1%−8.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | $0.87 | — | — |
| Oct 2026 | $1.72 | — | — |
| Jul 2026 | $1.10 | $1.21 | +10.0% |
| Apr 2026 | $1.06 | $1.10 | +3.8% |
| Jan 2026 | $0.84 | $0.89 | +6.0% |
| Oct 2025 | $1.60 | $1.70 | +6.2% |
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | $0.87 | — | — | $12.43B | — | — | — |
| Oct 30, 2026 | $1.72 | — | — | $15.20B | — | — | — |
| Jul 30, 2026 | $1.10 | $1.21 | +10.0% | $15.34B | $14.06B | −8.3% | −4.4% |
| Apr 23, 2026 | $1.06 | $1.10 | +3.8% | $12.68B | $12.94B | +2.1% | +1.3% |
| Jan 29, 2026 | $0.84 | $0.89 | +6.0% | $11.71B | $14.34B | +22.4% | +0.9% |
| Oct 24, 2025 | $1.60 | $1.70 | +6.2% | $11.11B | $15.43B | +38.9% | +4.3% |
| Jul 31, 2025 | |||||||
| Apr 24, 2025 | |||||||
| Jan 30, 2025 | |||||||
| Oct 25, 2024 | |||||||
| Jul 25, 2024 | |||||||
| Apr 25, 2024 | |||||||
| Feb 1, 2024 | |||||||
| Oct 27, 2023 | |||||||
| Jul 28, 2023 | |||||||
| Apr 27, 2023 | |||||||
| Feb 3, 2023 | |||||||
| Oct 28, 2022 | |||||||
| Jul 28, 2022 | |||||||
| Apr 28, 2022 | |||||||
| Feb 4, 2022 | |||||||
| Oct 28, 2021 | |||||||
| Jul 29, 2021 | |||||||
| Apr 28, 2021 | |||||||
| Feb 5, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Jul 29, 2020 | |||||||
| Apr 24, 2020 | |||||||
| Feb 6, 2020 | |||||||
| Oct 31, 2019 | |||||||
| Jul 29, 2019 | |||||||
| Apr 26, 2019 | |||||||
| Feb 7, 2019 | |||||||
| Oct 31, 2018 | |||||||
| Jul 31, 2018 | |||||||
| Apr 27, 2018 | |||||||
| Feb 7, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Jul 31, 2017 | |||||||
| Apr 28, 2017 | |||||||
| Feb 8, 2017 | |||||||
| Oct 28, 2016 | |||||||
| Jul 29, 2016 | |||||||
| Apr 29, 2016 | |||||||
| Feb 9, 2016 | |||||||
| Oct 29, 2015 | |||||||
| Jul 30, 2015 |